Artificial Intelligence In Genomics Market Size, Share, Growth, Forecast 2032
Artificial Intelligence In Genomics Market - By Technology (Machine Learning and Computer Vision), By End-User (Pharma and Research), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 568.1 Million | USD 15365.78 Million | 39.1% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
- 2.2. Artificial Intelligence In Genomics Market: Snapshot
- Chapter 3. Global Artificial Intelligence In Genomics Market– Industry Analysis
- 3.1. Artificial Intelligence In Genomics Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Massive use of next generation sequencing in genomics has resulted in rise in the precision and success of the healthcare sector. Hence, it has become imperative to combine this whule genome sequencing method with machine learning for improving the medical practice as well as improving the knowhow of diseases such as cancer. This will prompt the market growth over 2020-2026.
- 3.2.2. Thriving precision medicine market and need for exact whule genome synthesis has created huge growth avenues for artificial intelligence in genomics industry.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By End-User
- 3.4.2. Market attractiveness analysis By Technology
- Chapter 4. Global Artificial Intelligence In Genomics Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Artificial Intelligence In Genomics Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Technology launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Artificial Intelligence In Genomics Market– End-User Analysis
- 5.1. Global Artificial Intelligence In Genomics Market overview: By End-User
- 5.1.1. Global Artificial Intelligence In Genomics Market share, By End-User , 2019 and 2026
- 5.2. Pharma
- 5.2.1. Global Artificial Intelligence In Genomics Market By Pharma, 2016–2026 (USD Million)
- 5.3. Research
- 5.3.1. Global Artificial Intelligence In Genomics Market By Research, 2016–2026 (USD Million)
- 5.1. Global Artificial Intelligence In Genomics Market overview: By End-User
- Chapter 6. Global Artificial Intelligence In Genomics Market– Technology Analysis
- 6.1. Global Artificial Intelligence In Genomics Market overview: By Technology
- 6.1.1. Global Artificial Intelligence In Genomics Market share, By Technology, 2019 and 2026
- 6.2. Machine Learning
- 6.2.1. Global Artificial Intelligence In Genomics Market By Machine Learning , 2016–2026 (USD Million)
- 6.3. Computer Vision
- 6.3.1. Global Artificial Intelligence In Genomics Market By Computer Vision, 2016–2026 (USD Million)
- 6.1. Global Artificial Intelligence In Genomics Market overview: By Technology
- Chapter 7. Company Profiles
- 7.1. Deep Genomics (Canada)
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Technology Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. IBM (U.S.
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Technology Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. FDNA Inc. (U.S.)
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Technology Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. Microsoft (U.S.)
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Technology Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. Genoox Ltd. (U.S.)
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Technology Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. NVIDIA Corporation (U.S.)
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Technology Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. Lifebit (UK)
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Technology Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. DNAnexus Inc. (U.S.).
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Technology Portfolio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. Diploid (Belgium)
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Technology Portfolio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.10. PrecisionLife Ltd (UK)
- 7.10.1. Overview
- 7.10.2. Financials
- 7.10.3. Technology Portfolio
- 7.10.4. Business Strategy
- 7.10.5. Recent Development
- 7.11. Data4Cure Inc. (U.S.)
- 7.11.1. Overview
- 7.11.2. Financials
- 7.11.3. Technology Portfolio
- 7.11.4. Business Strategy
- 7.11.5. Recent Development
- 7.12. MulecularMatch Inc. (U.S.)
- 7.12.1. Overview
- 7.12.2. Financials
- 7.12.3. Technology Portfolio
- 7.12.4. Business Strategy
- 7.12.5. Recent Development
- 7.13. Freenome Huldings, Inc. (U.S.)
- 7.13.1. Overview
- 7.13.2. Financials
- 7.13.3. Technology Portfolio
- 7.13.4. Business Strategy
- 7.13.5. Recent Development
- 7.14. SOPHiA GENETICS (U.S.)
- 7.14.1. Overview
- 7.14.2. Financials
- 7.14.3. Technology Portfolio
- 7.14.4. Business Strategy
- 7.14.5. Recent Development
- 7.15. Verge Genomics (U.S.)
- 7.15.1. Overview
- 7.15.2. Financials
- 7.15.3. Technology Portfolio
- 7.15.4. Business Strategy
- 7.15.5. Recent Development
- 7.16. Fabric Genomics Inc. (U.S.)
- 7.16.1. Overview
- 7.16.2. Financials
- 7.16.3. Technology Portfolio
- 7.16.4. Business Strategy
- 7.16.5. Recent Development
- 7.17. Cambridge Cancer Genomics (UK)
- 7.17.1. Overview
- 7.17.2. Financials
- 7.17.3. Technology Portfolio
- 7.17.4. Business Strategy
- 7.17.5. Recent Development
- 7.18. BenevulentAI (UK)
- 7.18.1. Overview
- 7.18.2. Financials
- 7.18.3. Technology Portfolio
- 7.18.4. Business Strategy
- 7.18.5. Recent Development
- 7.1. Deep Genomics (Canada)
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
4. Porter’s Five Forces Analysis
5. Global Artificial Intelligence In Genomics Market attractiveness, By End-User
6. Global Artificial Intelligence In Genomics Market attractiveness, By Technology
7. Global Artificial Intelligence In Genomics Market Share by End-User ,2019 and 2026 (USD Million)
8. Global Artificial Intelligence In Genomics Market by Pharma ,2016–2026 (USD Million)
9. Global Artificial Intelligence In Genomics Market by Research,2016–2026 (USD Million)
10. Global Artificial Intelligence In Genomics Market Share by Technology ,2019 and 2026 (USD Million)
11. Global Artificial Intelligence In Genomics Market by Machine Learning , and,2016–2026 (USD Million)
12. Global Artificial Intelligence In Genomics Market by Computer Vision,2016–2026 (USD Million)
13. Global Artificial Intelligence In Genomics Market share, by Region, 2019 and 2026
14. North America Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
15. Europe Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
16. Asia Pacific Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
17. Latin America Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
18. The Middle East and Africa Artificial Intelligence In Genomics Market, 2016–2026 (USD Million)
Table Of Tables
List of Tables
1. Global Artificial Intelligence In Genomics Market: snapshot
2. Drivers of the Artificial Intelligence In Genomics Market: impact analysis
3. North America Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
4. North America Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
5. The U.S. Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
6. The U.S. Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
7. Rest of North America Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
8. Rest of North America Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
9. Europe Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
10. Europe Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
11. UK Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
12. UK Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
13. France Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
14. France Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
15. Germany Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
16. Germany Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
17. Rest of Europe Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
18. Rest of Europe Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
19. Asia Pacific Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
20. Asia Pacific Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
21. China Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
22. China Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
23. Japan Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
24. Japan Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
25. India Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
26. India Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
27. Rest of Asia Pacific Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
28. Rest of Asia Pacific Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
29. Latin America Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
30. Latin America Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
31. Brazil Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
32. Brazil Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
33. Rest of Latin America Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
34. Rest of Latin America Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
35. The Middle East and Africa Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
36. The Middle East and Africa Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
37. Saudi Arabia Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
38. Saudi Arabia Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
39. South Africa Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
40. South Africa Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
41. Rest of the Middle East & Africa Artificial Intelligence In Genomics Market revenue, By End-User, 2016–2026 (USD Million)
42. Rest of the Middle East & Africa Artificial Intelligence In Genomics Market revenue, By Technology, 2016–2026 (USD Million)
Methodology
FrequentlyAsked Questions
AI in genomics analyzes genetic data using algorithms. It supports disease research and personalized medicine
The global Artificial Intelligence In Genomics market is expected to be driven by the advancements in sequencing and precision medicine. Demand for faster data analysis and drug discovery boosts adoption.
According to study, the global Artificial Intelligence In Genomics market size was worth around USD 568.1 Million in 2023 and is predicted to grow to around USD 15365.78 Million By 2032.
The global Artificial Intelligence In Genomics market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 39.1% during the forecast period from 2024-2032.
The global Artificial Intelligence In Genomics industry is projected to be challenged by Challenges include data privacy concerns, high computational requirements, and limited standardized datasets.
The Opportunities include precision medicine, drug discovery acceleration, rare disease research, and declining sequencing costs will offer significant growth opportunities in the Artificial Intelligence In Genomics market.
AI-driven variant interpretation; faster sequencing analytics; applications in precision medicine and drug discovery are the emerging trends and innovations impacting the Artificial Intelligence In Genomics market.
The global Artificial Intelligence In Genomics market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Artificial Intelligence In Genomics market are; Deep Genomics (Canada), IBM (U.S.), FDNA Inc. (U.S.), Microsoft (U.S.), Genoox Ltd. (U.S.), NVIDIA Corporation (U.S.), Lifebit (UK), BenevolentAI (UK), Cambridge Cancer Genomics (UK), Fabric Genomics Inc. (U.S.), Verge Genomics (U.S.), SOPHiA GENETICS (U.S.), Freenome Holdings, Inc. (U.S.), MolecularMatch Inc. (U.S.), Data4Cure Inc. (U.S.), PrecisionLife Ltd (UK), Diploid (Belgium), and DNAnexus Inc. (U.S.) and others.
The report explores crucial aspects of the Artificial Intelligence In Genomics market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
